Neurocognitive function among HIV-infected children on protease inhibitor -based versus non-protease inhibitor based antiretroviral therapy in Uganda: a pilot study

被引:1
|
作者
Nalwanga, Damalie [1 ,2 ]
Musiime, Victor [1 ,3 ]
Bangirana, Paul [4 ]
Nishiguchi, Erika Phelps [5 ]
Kiggwe, Andrew [2 ]
Ssesanga, Titus [3 ]
Ssenkusu, John M. [6 ]
Musoke, Philippa [1 ]
Cusick, Sarah E. [7 ]
机构
[1] Makerere Univ, Sch Med, Dept Paediat & Child Hlth, Coll Hlth Sci, POB 7072, Kampala, Uganda
[2] Makerere Univ Lung Inst, POB 7749, Kampala, Uganda
[3] Joint Clin Res Ctr, Res Dept, POB 10005, Kampala, Uganda
[4] Makerere Univ, Sch Med, Dept Psychiat, Coll Hlth Sci, POB 7072, Kampala, Uganda
[5] Univ Washington, Dept Paediat, Div Dev Behav Paediat, Seattle, WA 98195 USA
[6] Makerere Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Coll Hlth Sci, POB 7072, Kampala, Uganda
[7] Univ Minnesota, Dept Paediat, Minneapolis, MN USA
基金
美国国家卫生研究院;
关键词
Neurocognitive function; Children; HIV; ART; NEUROPSYCHOLOGICAL PERFORMANCE; COGNITIVE IMPAIRMENT; NAIVE; DEFICITS; OUTCOMES; CARE; ART;
D O I
10.1186/s12887-021-02676-2
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background HIV infection is associated with significant neurocognitive deficits making maximization of cognitive function among children receiving antiretroviral therapy (ART) a public health imperative. Non-protease inhibitors (non-PIs) achieve higher drug levels in the cerebral spinal fluid (CSF) compared to PIs, potentially leading to better neurocognitive function by reducing CSF viral load and inflammation. ART that maximises children's neurodevelopment and school achievement could result in improved quality of life and productivity as adults, but little research to date has examined whether non-PI ART is associated with better neurocognitive outcomes. We compared the neurocognitive function between children living with HIV receiving PI-based and non PI-based ART. Methods We recruited a consecutive sample of clinically stable Ugandan children living with HIV aged 5-12 years who received PI-based or non PI-based ART for >= 1 year (viral load < 1000 copies). Neurocognitive function was assessed using the Kaufman Assessment Battery for Children, the Test of Variables of Attention, and Bruininks-Oseretsky Test of Motor Proficiency. Age-adjusted neurocognitive z-scores for the two groups were compared using linear regression models in STATA version 13. The Hommel's method was used to adjust for multiple testing. Results We enrolled 76 children living with HIV; 34 on PI ART and 42 on non-PI ART. Mean (+/- SD) age was greater in the non-PI vs. PI group (9.5 +/- 1.9 vs. 8.5 +/- 2.0) years (p = 0.03). Children in the non-PI group had lower socioeconomic scores (5.7 +/- 3.3 vs. 7.4 +/- 2.8, p = 0.02). There was no difference in neurocognitive function between the groups (adjusted p > 0.05) for KABC and TOVA. Children in the PI group had better total BOT scores than their counterparts (46.07 +/- 1.40) vs. 40.51 (1.24), p = 0.03). Conclusions We detected no difference in neurocognitive function among children on PI and non PI-based ART therapy based on KABC and TOVA tests. Children on PI based ART had better motor function than their counterparts. We recommend a prospective study with a larger sample size.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Factors associated with adherence to antiretroviral therapy among HIV-infected children in Pokhara, Nepal: a cross-sectional study
    Bastola, Ramchandra
    Sigdel, Bhawana
    Subedi, Krishna
    Ghimire, Amrita
    Ghimire, Sunita
    HIV & AIDS REVIEW, 2024, 23 (01): : 66 - 71
  • [42] Impact of a tenofovir disoproxil fumarate plus ritonavir-boosted protease inhibitor-based regimen on renal function in HIV-infected individuals: a prospective, multicenter study
    Cao, Ying
    Han, Yang
    Xie, Jing
    Cui, Qu
    Zhang, Lixia
    Li, Yijia
    Li, Yanling
    Song, Xiaojing
    Zhu, Ting
    Li, Taisheng
    BMC INFECTIOUS DISEASES, 2013, 13
  • [43] Impact of a tenofovir disoproxil fumarate plus ritonavir-boosted protease inhibitor-based regimen on renal function in HIV-infected individuals: a prospective, multicenter study
    Ying Cao
    Yang Han
    Jing Xie
    Qu Cui
    Lixia Zhang
    Yijia Li
    Yanling Li
    Xiaojing Song
    Ting Zhu
    Taisheng Li
    BMC Infectious Diseases, 13
  • [44] Incidence and predictors of early loss to follow up among patients initiated on protease inhibitor-based second-line antiretroviral therapy in southwestern Uganda
    Edwin Nuwagira
    Boniface A. E. Lumori
    Rose Muhindo
    Michael Kanyesigye
    Abdallah Amir
    Winnie Muyindike
    Conrad Muzoora
    AIDS Research and Therapy, 18
  • [45] Pilot study of zidovudine-lamivudine combination therapy in vertically HIV-infected antiretroviral-naive children
    Horneff, G
    Adams, O
    Wahn, V
    AIDS, 1998, 12 (05) : 489 - 494
  • [46] Incidence and predictors of early loss to follow up among patients initiated on protease inhibitor-based second-line antiretroviral therapy in southwestern Uganda
    Nuwagira, Edwin
    Lumori, Boniface A. E.
    Muhindo, Rose
    Kanyesigye, Michael
    Amir, Abdallah
    Muyindike, Winnie
    Muzoora, Conrad
    AIDS RESEARCH AND THERAPY, 2021, 18 (01)
  • [47] Hypofibrinolytic state in HIV-1-infected patients treated with protease inhibitor-containing highly active antiretroviral therapy
    Koppel, K
    Bratt, G
    Schulman, S
    Bylund, H
    Sandström, E
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 29 (05) : 441 - 449
  • [48] Impact of Protease Inhibitor-Based Antiretroviral Therapy on Tacrolimus Intrapatient Variability in HIV-Positive Kidney Transplant Recipients
    Cooper, Megan
    Dunne, Ian
    Kuten, Samantha
    Curtis, Anna
    Graviss, Edward A.
    Nguyen, Duc T.
    Hobeika, Mark
    Gaber, A. Osama
    TRANSPLANTATION PROCEEDINGS, 2021, 53 (03) : 984 - 988
  • [49] Monotherapy with lopinavir/ritonavir versus standard of care in HIV-infected patients virologically suppressed while on treatment with protease inhibitor-based regimens: results from the MoLo Study
    Gianotti, Nicola
    Poli, Andrea
    Galli, Massimo
    Pan, Angelo
    Rizzardini, Giuliano
    Soria, Alessandro
    Viale, Pierluigi
    Di Biagio, Antonio
    Quirino, Tiziana
    Vigano, Paolo
    Bonfanti, Paolo
    Monforte, Antonella d'Arminio
    Fortino, Ida
    Lazzarin, Adriano
    NEW MICROBIOLOGICA, 2014, 37 (04) : 439 - 448
  • [50] Short term adherence tool predicts failure on second line protease inhibitor-based antiretroviral therapy: an observational cohort study
    Court, Richard
    Leisegang, Rory
    Stewart, Annemie
    Sunpath, Henry
    Murphy, Richard
    Winternheimer, Philip
    Ally, Mashuda
    Maartens, Gary
    BMC INFECTIOUS DISEASES, 2014, 14